C12Y 204/02019
Nicotinate-nucleotide diphosphorylase
Official title: Nicotinate-nucleotide diphosphorylase (carboxylating) (2.4.2.19)
C12Y204/02019 (Nicotinate-nucleotide diphosphorylase) appears on 3 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 11
- Assignees
- 9
- Inventors
- 39
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 2 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Expression system for product manufacturing14 Oct 2025US 12,442,006 B2Novel Biotechnology USA, Inc.
- Nicotinamide riboside production in filamentous fungi14 May 2024US 11,981,889 B2Dyadic International (USA), Inc.
- Recombinant microorganism producing quinolinic acid and method for producing quinolinic acid using same9 Jul 2019US 10,344,287 B2Cj Cheiljedang Corporation
- Nicotinamide adenine dinucleotide devices and compositions and methods for making the same27 Aug 2026US 2026/0250695 A1Bio Capital Holdings, LLC
- Protein devices and compositions and methods for making the same30 Jul 2026US 2026/0218214 A1Bio Capital Holdings, LLC
- Expression system for product manufacturing22 Jan 2026US 2026/0022391 A1Novel Biotechnology USA, Inc.
- Metabolic engineering of actinomycetes by single cell mutant selection24 Jul 2025US 2025/0236874 A1Turun Yliopisto
- Expression system for product manufacturing17 Jul 2025US 2025/0230447 A1Novel Biotechnology USA, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.